Medical researchers have developed an ‘in vivo priming’ with heart-derived bioink. Using engineered stem cells and 3D bioprinting technology, they began developing medicines for cardiovascular diseases.
Medical researchers have developed an ‘in vivo priming’ with heart-derived bioink. Using engineered stem cells and 3D bioprinting technology, they began developing medicines for cardiovascular diseases.